We are in the process of starting up the DELIVR consortium with Radboud Medical Centre (Nijmegen, NL), Quirem Medical BV ( NL) and ADIS (Lausanne, CH) over the next few months. The target is to further enable fully MRI guided embolization therapy for liver cancer at the same time also developing our AI supported TRACKR software to guide and position microcatheters in the liver. Device development and Machine Learning hand-in-hand to improve cancer therapy! Anticipated start is August 1st 2022, and we are still hiring a machine learning specialist to extend our team.